Portal:CPTAC

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(typo)
(Adding hallmark display)
Line 24: Line 24:
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal
|<!-- TITLE OF BOX -->
|<!-- TITLE OF BOX -->
-
<big>''Useful Links''</big>   
+
<big>''Cancer Hallmark Categories''</big>   
|<!-- EDIT LINK -->   
|<!-- EDIT LINK -->   
-
{{FULLPAGENAME}}/Other
+
{{FULLPAGENAME}}/Hallmarks
|<!-- CONTENT LINK -->
|<!-- CONTENT LINK -->
-
{{FULLPAGENAME}}/Other    
+
{{FULLPAGENAME}}/Hallmarks    
|  
|  
}}
}}
Line 47: Line 47:
 +
{{{{FULLPAGENAME}}/box-normal
 +
|<!-- TITLE OF BOX -->
 +
<big>''Useful Links''</big> 
 +
|<!-- EDIT LINK --> 
 +
{{FULLPAGENAME}}/Other
 +
|<!-- CONTENT LINK -->
 +
{{FULLPAGENAME}}/Other   
 +
|
 +
}}
</div>
</div>

Revision as of 17:33, 3 October 2017

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects


edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

Translation inhibitors in chronically activated PDGFRA cells (Homo sapiens)

Image does not exist
Translation inhibitors in chronically activated PDGFRA cells
Evading growth suppressors

Retinoblastoma gene in cancer (Homo sapiens)

Image does not exist
Retinoblastoma gene in cancer
Activating invasion and metastasis

Integrin-mediated cell adhesion (Homo sapiens)

Image does not exist
Integrin-mediated cell adhesion
Enabling replicative immortality

ncRNAs in Wnt signaling in hepatocellular carcinoma (Homo sapiens)

Image does not exist
ncRNAs in Wnt signaling in hepatocellular carcinoma
Inducing angiogenesis

Hedgehog signaling (Homo sapiens)

Image does not exist
Hedgehog signaling
Resisting cell death

Apoptosis (Homo sapiens)

Image does not exist
Apoptosis
Deregulating cellular energetics

Hereditary leiomyomatosis and renal cell carcinoma pathway (Homo sapiens)

Image does not exist
Hereditary leiomyomatosis and renal cell carcinoma pathway
Genome instability and mutation

Base excision repair (Homo sapiens)

Image does not exist
Base excision repair
Tumor promoting inflammation

IL1 signaling (Homo sapiens)

Image does not exist
IL1 signaling
Avoiding immune destruction

Altered glycosylation of MUC1 in tumor microenvironment (Homo sapiens)

Image does not exist
Altered glycosylation of MUC1 in tumor microenvironment
Therapeutics

Photodynamic therapy-induced NF-kB survival signaling (Homo sapiens)

Image does not exist
Photodynamic therapy-induced NF-kB survival signaling

edit  

Featured Pathways


edit  

Useful Links

Personal tools